Clear cell carcinoma of the uterine cervix in a 16-year old patient 
- a case report by Sobiczewski, P. et al.
Introduction
Some 7 to 15 % of cervical cancers are adenocarcinomas
and their incidence has recently increased with reference
to squamous cell carcinoma [1, 2]. The higher rate of
clear cell carcinoma has been observed in girls and young
women exposed in utero to hormonal treatment with
diethylstilbestrol (DES).The age of the patients with clear
cell carcinoma induced by DES ranged from 15 to
25 years, unlike the age of patients with spontaneous
tumors (unrelated to DES exposure) in which the disease
typically occurs at an older age (50-80 years) [1, 3].
Case report
A 16-year old patient was admitted to the pediatric
department of a local hospital on the 28-th of February
2002 with the symptoms of anemia, general weakness,
palpitation and hair loss. Total blood cell count revealed
low erythrocyte level (RBC 3.97 x 1012/L). Laboratory
test showed decreased iron (Fe) level of 63mg% and
hemoglobin (Hb) 7.8 g/dl. The medical history noted
polymenorrhea and hypermenorrhea occurring for
2 years. Gynecological examination revealed a mass of
hemorrhagic appearance extending in the 1/3 upper part
of the vagina.
A biopsy of the tumor revealed clear cell carcinoma
of high-grade (G3).
Ultrasonographic examination and consultation in
the Gynecologic Department of the Medical Academy
in Warsaw confirmed the diagnosis of uterine cervical
tumor. The patient was given packed red blood cells due
to the low hemoglobin level and was referred to the
Department of Gynecological Oncology of the Maria
Sk∏odowska-Curie Memorial Cancer Center for further
evaluation and treatment. Gynecological examination
confirmed the presence of an exophytic cervical lesion
4 cm in diameter. Rectovaginal examination did not
reveal parametrial induration. The parametrium thickness
measured by transvaginal echography was 11mm on the
right side and 9 mm on the left side, without any signs of
neoplasmatic infiltration. Evaluation of the pelvis with
NMR imaging showed a cervical tumor 45 x 48 mm and
also excluded parametrial invasion (Figures 1, 2). Even-
tually, the tumor was clinically diagnosed as FIGO stage
I b and the patient was scheduled for surgery. On the
25th of March 2002 radical hysterectomy, bilateral
salpingo-oophorectomy and pelvic lymphadenectomy (the
Wertheim-Meigs operation) was performed. Postope-
rative recovery was uncomplicated and the patient was
discharged after 8 days.
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We report a case of clear cell carcinoma of the uterine cervix not related to DES (diethylstilboestrol ) exposure in a 16-year old
patient. USG and MRI imaging were useful in excluding parametrial infiltration and assessing the stage of disease. Combined
modality treatment consisted of Wertheim-Meigs operation followed by adjuvant  HDR (high-dose-rate)  brachytherapy to the
vaginal vault .
Jasnokomórkowy rak szyjki macicy u 16-letniej chorej - opis przypadku
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The uterus with parametrial margins, both adnexas
and 21 pelvic lymph nodes was sent for pathologic
examination. An exophytic tumor (45 mm x 45 mm x 35
mm) of papillary pattern was found on the vaginal portion
of uterine cervix. Macroscopically on cross-section, the
tumor was creamy, solid and dense. Microscopic
examination confirmed the initial diagnosis of clear cell
adenocarcinoma of the uterine cervix (Figure 3). Cystic
structures with papillary proliferation (Figure 4) and
focally columnar cells were found on histopathological
examination. The dark nuclei were located in the base
part of epithelial cells. The representative sections were
routinely stained by H&E. In 20% of cells a bright
colored cytoplasm and in 80% a rose colored cytoplasm
was found. The mucus staining in cells was negative. The
tumor infiltration did not exceed 1/2 of the cervix
diameter. The parametrial tissue and all lymphnodes were
negative for carcinoma.
From the 19-th of April to the 17-th of May 2002
adjuvant intracavitary brachytherapy consisting of 3
repeated applications of 7,5 Gy by HDR remote
afterloading technique on vaginal vault was applied. The
patient remains under close follow-up and has no
symptoms of recurrence to date.
Discussion
Clear cell adenocarcinoma of the uterine cervix and
vagina was rare until the 1970s, when a significant
increase in incidence in young patients between 8 and 29
years of age has been noticed. The growing number of
cases was associated with the teratogenic effect of DES on
in utero exposed female fetus. DES was widely prescribed
to pregnant women as a preventive therapy against
abortion in the late 1940s, especially in the USA. Data
from the Registry for Research on Hormonal Trans-
placental Carcinogenesis in the USA based on 170 cases
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Figure 1
Figures 1, 2. NMR imaging: saggital and axial T1 and T2 - weighted images were obtained and showed the cervical tumor with no parametrial
invasion
Figure 2
Figure 3. H&E x 100 Clear cell carcinoma infiltrating cervical canal Figure 4. H&E x 200 The cystic structures with papillary proliferation
of cervical and vaginal carcinoma highly suggested that
87% of cases of vaginal cancer and 68% of cases of
cervical cancer of clear cell type were related to the intake
of hormonal treatment by mothers during the first and
second trimester of pregnancy (during the first 18 weeks
in all cases) [3]. The estimated risk of developing a clear
cell carcinoma of vagina or cervix was 0.14 to 1.4 in 1000
women exposed in utero to DES. The most common
symptoms were irregular bleedings and vaginal discharges.
Subsequent analysis of the Registry in 1979 based on 384
cases have confirmed the epidemiological data and
allowed to draw new conclusions. Overall 5-year survival
rate was 78% and was higher in the group of patients
aged 19 years and older (83%), as compared to patients
14 years and less (71%). Worse outcome in young patients
was probably related to the solid pattern of the tumor
more common in this age group [3, 4]. Furthermore, the
Registry data has shown better prognosis in patients with
DES-induced cancer than in the group with spontaneous
clear cell carcinoma (5 year survival 84% versus 69%)
[4, 5]. The highest incidence of the clear cell carcinoma
was observed in the group of patients born from 1951 to
1953.
Until January 1999, 705 cases of clear cell carcinoma
of the uterine cervix and vagina have been registered,
mostly in the United States. Exposure to DES was
reported for 60 % of cases, in 30% patients the neoplasm
was non related to hormonal exposure and in 10% of
cases the history was unobtainable or investigation
incomplete [5]. Clear cell carcinomas not related to DES
account for 2-6 % of adenocarcinomas of the uterine
cervix and the 10-year survival rate for the patients with
all stages is about 57%, and is similar to other cervical
adenocarcinomas [7].The recommended treatment is
surgery with adjuvant radiotherapy. Different pathogenic
factors were considered as affecting the development of
clear cell carcinoma, mostly hormonal but also genetic.
The data from the Central Netherlands Registry
indicated the bimodal age distribution with two distinct
peaks: one at young age (a mean age of 26 years) and
one at older age (a mean age of 71 year) [6]. In the
Netherlands study this bimodal age distribution was still
present even if the DES-exposed women were excluded.
This observation, not reported previously, supports the
hypothesis that risk factors other than DES exposure may
play an important role in carcinogenesis [6]. It may
suggest that there exists a risk period after menarche and
menopause related to hormonal changes or to population
with constitutional sensitivity for carcinogenesis [6].
A case report available in literature concerned a 17-year
old patient with pathological genotype 46XX/47XX,
mental retardation and non-DES-related clear cell
carcinoma of the vagina. Successful treatment with
chemotherapy (CAP) was applied resulting in complete
remission. Pathological genotype and genetic aberration
may lie beneath the development of clear cell carcinoma
[8]. Ethiopatogenesis may be complex and in DES-related
cancers, the hormonal factor may act as cocarcinogene
and faciacilitate, along with others factors, the malignant
transformation of the epithelium.
Our demonstrated case is casuistic due to the lack of
DES exposure and should be classified as spontaneous,
rarely occurring in young women. Radical surgery with
adjuvant brachytherapy is the recommended treatment
in this type of cancer. Preoperative imaging (USG, NMR)
may be useful for precise assessment of the stage of the
disease, which is crucial for the choice of the appropriate
treatment.
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